HSHHSH Health Technology Supplier Hub

All suppliers

Showing 1–25 of 51 · Clinical AI & decision support

AbridgeHQ United States · North America
Clinical AI & decision support

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Ada HealthHQ Germany · Europe
Clinical AI & decision supportPatient engagement & access

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
AidocHQ Israel · Middle East & Africa
Clinical AI & decision supportImaging, PACS & RIS

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
AlcidionHQ Australia · Asia-Pacific
Clinical AI & decision supportElectronic health records (EHR/EPR)Patient flow & operations

FY2026 revenue A$51.6m (+27.0%); net margin 4.5%; net income A$2.3m.

Underlying EBITDA A$6.8m (+34%); A$20.6m cash, no debt.

Financial health: FairRisk summary →
No reviews yet
View profile
Ambience HealthcareHQ United States · North America
Clinical AI & decision support

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Annalise.aiHQ Australia · Asia-Pacific
Clinical AI & decision supportImaging, PACS & RIS

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
BrainomixHQ United Kingdom · Europe
Clinical AI & decision supportImaging, PACS & RIS

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
CaresyntaxHQ United States · North America
Clinical AI & decision supportSurgical & theatre systems

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
CortiHQ Denmark · Europe
Clinical AI & decision support

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Elsevier HealthHQ Netherlands · Europe
Clinical AI & decision support

Parent RELX (REL.L) group FY2025 revenue £9.59bn (+1.7%); operating margin 31.6%; net income £2.08bn.

Figures cover the whole listed group, not this business alone.

Financial health: StrongRisk summary →
No reviews yet
View profile
GE HealthCareHQ United States · North America
Clinical AI & decision supportImaging, PACS & RISMedical devices & monitoring

FY2025 revenue $20.62bn (+4.8%); operating margin 13.4%; net income $2.08bn.

Cash $4.51bn; debt $10.00bn.

Financial health: StrongRisk summary →
No reviews yet
View profile
GleamerHQ France · Europe
Clinical AI & decision supportImaging, PACS & RIS

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Google CloudHQ United States · North America
Clinical AI & decision supportInfrastructure & cloud

Parent Alphabet (GOOGL) group FY2025 revenue $402.84bn (+15.1%); operating margin 32.0%; net income $132.17bn.

Figures cover the whole listed group, not this business alone.

Financial health: StrongRisk summary →
No reviews yet
View profile
Health CatalystHQ United States · North America
Clinical AI & decision supportPopulation health & analytics

FY2025 revenue $311.1m (+1.5%); operating margin -51.7%; net loss $178.0m.

Cash $95.7m; debt $153.3m.

Financial health: WeakRisk summary →
No reviews yet
View profile
HeartFlowHQ United States · North America
Clinical AI & decision supportImaging, PACS & RIS

FY2025 revenue $176.0m (+40.0%); operating margin -36.4%; net loss $116.8m.

No debt; $280.2m cash.

Financial health: WeakRisk summary →
No reviews yet
View profile
Heidi HealthHQ Australia · Asia-Pacific
Clinical AI & decision support

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Hippocratic AIHQ United States · North America
Clinical AI & decision support

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Ibex Medical AnalyticsHQ Israel · Middle East & Africa
Clinical AI & decision supportLaboratory & pathology (LIMS)

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
IBMHQ United States · North America
Clinical AI & decision supportInfrastructure & cloud

FY2025 revenue $67.53bn (+7.6%); pre-tax margin 15.3%; net income $10.59bn.

Cash $14.50bn; debt $61.30bn.

Financial health: StrongRisk summary →
No reviews yet
View profile
iCADHQ United States · North America
Clinical AI & decision supportImaging, PACS & RIS

Part of RadNet (RDNT).

Latest full-year results not yet captured by HSH.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
InfermedicaHQ Poland · Europe
Clinical AI & decision support

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Isabel HealthcareHQ United Kingdom · Europe
Clinical AI & decision support

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Kheiron Medical TechnologiesHQ United Kingdom · Europe
Clinical AI & decision supportImaging, PACS & RIS

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
LeanTaaSHQ United States · North America
Clinical AI & decision supportPatient flow & operations

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
LunitHQ South Korea · Asia-Pacific
Clinical AI & decision supportImaging, PACS & RIS

Listed (328130.KQ).

Latest full-year results not yet captured by HSH.

Financial health: Not assessedRisk summary →
No reviews yet
View profile